Overexpression of CSRP1 Suppresses Cell Viability and Enhances the Anti-Cancer Effects of Anti-PD-L1 Therapy in Renal Cell Carcinoma
<i>CSRP1</i> may play a role in regulating cell viability, migration, drug resistance, and possibly innate immunity in RCC. These findings suggest that <i>CSRP1</i> could increase the efficacy of targeted drugs and immunotherapy in combination treatment strategies for RCC.
Authors
- D. Zhang (ORCID: https://orcid.org/0000-0001-7921-6944)
- Bo Yang (ORCID: https://orcid.org/0000-0002-6002-6443)
- Ying Ke (ORCID: https://orcid.org/0000-0001-8511-109X)
- Yi He (ORCID: https://orcid.org/0009-0009-5507-7906)
- Y. Yao (ORCID: https://orcid.org/0009-0002-0326-6130)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
- Affiliated Zhongshan Hospital of Dalian University (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-11-27
- DOI
- https://doi.org/10.31083/fbl46252
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dalian Medical University